FDA Clearance Tracker · K223020
VS3-Iridium System (VS3-IR)
Last checked: Nov 19, 2026Latest source record: Oct 28, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Oct 28, 2022
Substantially Equivalent
Time to decision
29 days
Received Sep 29, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K223020
- Device name
- VS3-Iridium System (VS3-IR)
- Applicant
- Visionsense, Ltd.
- Applicant location
- Petach Tikva, Hamerkaz, IL
- Received
- Sep 29, 2022
- Decided
- Oct 28, 2022
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Confocal Optical Imaging (OWN)
- Device class
- Class II
- Regulation
- 21 CFR 876.1500
- Specialty
- GI, Urology & Nephrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OWN. The earliest in FDA's data is K111047, decided Aug 8, 2011.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K223020
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Visionsense, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VS3 Iridium Sytem510(k)
K210265 · Decided Nov 22, 2021 · 294 days after receipt
Device type: Confocal Optical Imaging (OWN) · GI, Urology & Nephrology
- Trans-anal Introducer510(k)
K171208 · Decided Feb 5, 2018 · 286 days after receipt
Device type: Endoscopic Access Overtube, Gastroenterology-Urology (FED) · GI, Urology & Nephrology
K153548 · Decided Feb 22, 2016 · 73 days after receipt
Device type: Arthroscope (HRX) · Orthopedic Surgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.